EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering

Bing Fu, Junhui Ying, Qingwei Chen, Qili Zhang, Jiajie Lu, Zhiwen Zhu, Ping Yu

Frontiers in Microbiology · 16.01.2023 · 13

DOI: 10.3389/fmicb.2022.1111790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 16.01.2023. Verfasst von Bing Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, to construct the riboflavin-producing strain R1, five key genes, ribA , ribB , ribC , ribD , and ribE , were cloned and ligated to generate the plasmid pET-AE, which was overexpressed in Escherichia coli BL21. The R1 strain accumulated 182.65 ± 9.04 mg/l riboflavin. Subsequently, the R2 strain was constructed by the overexpression of zwf harboring the constructed plasmid pAC-Z in the R1 strain. Thus, the level of riboflavin in the R2 strain increased to 319.01 ± 20.65 mg/l (74.66% increase). To further enhance ribB transcript levels and riboflavin production, the FMN riboswitch was deleted from E. coli BL21 with CRISPR/Cas9 to generate the R3 strain. The R4 strain was constructed by cotransforming pET-AE and pAC-Z into the R3 strain. Compared to those of E. coli BL21, the ribB transcript levels of R2 and R4 improved 2.78 and 3.05-fold, respectively. The R4 strain accumulated 437.58 ± 14.36 mg/l riboflavin, increasing by 37.17% compared to the R2 strain. These results suggest that the deletion of the FMN riboswitch can improve the transcript level of ribB and facilitate riboflavin production. A riboflavin titer of 611.22 ± 11.25 mg/l was achieved under the optimal fermentation conditions. Ultimately, 1574.60 ± 109.32 mg/l riboflavin was produced through fed-batch fermentation with 40 g/l glucose. This study contributes to the industrial production of riboflavin by the recombinant E. coli BL21.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9Escherichia coli BL21FMN riboswitchmetabolic engineeringriboflavin

Autor:innen und Institutionen

  • College of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang, China.
  • College of Forestry Science and Technology, Lishui Vocational and Technical College, Lishui, Zhejiang, China.

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Fu, B., Ying, J., Chen, Q., Zhang, Q., Lu, J., Zhu, Z., & Yu, P. (2023). Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering. Frontiers in Microbiology, 13. https://doi.org/10.3389/fmicb.2022.1111790

Vancouver

Fu B, Ying J, Chen Q, Zhang Q, Lu J, Zhu Z, et al. Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering. Frontiers in Microbiology. 2023;13. doi:10.3389/fmicb.2022.1111790

BibTeX
@article{Fu2023,
  author = {Fu, Bing and Ying, Junhui and Chen, Qingwei and Zhang, Qili and Lu, Jiajie and Zhu, Zhiwen and Yu, Ping},
  title = {Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fmicb.2022.1111790}
}
Kostenlos starten →